9Indexed trials
drug · Product Intelligence
Matching Placebo
Pipeline Intelligence
Matching Placebo: 9 indexed trials, 8 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
8Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT00627640Newron Pharmaceuticals SPA · parkinsonsPHASE3
NCT01435928Sumitomo Pharma America, Inc. · schizophreniaPHASE3
NCT02127476Kyowa Kirin Co., Ltd. · alzheimersPHASE1
NCT03131453Novartis Pharmaceuticals · alzheimersPHASE2, PHASE3
NCT03355209Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. · other_neurologyPHASE3
NCT03481959Assistance Publique - Hôpitaux de Paris · adhdPHASE3
NCT03735901University Hospital, Basel, Switzerland · strokePHASE3
NCT05136885Merit E. Cudkowicz, MD · alsPHASE2, PHASE3
NCT05842941Merit E. Cudkowicz, MD · alsPHASE2, PHASE3
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.